Business Monitor International’s (BMI) “India Pharmaceuticals and Healthcare Report,” published last Thursday, predicts that over the next five years the Indian drug market will grow at a rate of 5.8 per cent a year.

The authors argue that global economic woes will force governments worldwide to look at ways of controlling healthcare spending and suggest that India’s plentiful supply of cheap drugs represent a significant cost-saving opportunity.